Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Edelstein

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer & Clinical Oncology|March 1, 1986
Two types of tumour sensitivity test compared for platinum derivativesL M van Putten, R J Middeldorp, M B Edelstein, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cell kinetic factors, single drugs and combinationP Lelieveld, J H Mulder, M B Edelstein, et al.
European Journal of Cancer|May 1, 1978
Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapyJ H Mulder, M B Edelstein, P Lelieveld, et al.
Journal of Experimental Therapeutics & Oncology|November 1, 1996
Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysisA Nakeff, M A KuKuruga, J E Media, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1983
Comparison between macroscopic and microscopic evaluation of tumour responsiveness using the subrenal capsule assayM B Edelstein, H H Fiebig, T Smink, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1984
Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugsM B Edelstein, T Smink, D J Ruiter, et al.
Cancer Treatment Reports|January 1, 1983
Model studies in adjuvant chemotherapyJ H Mulder, J de Ruiter, M B Edelstein, et al.
Investigational New Drugs|January 1, 1990
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group studyM B Edelstein, J J Crowley, F A Valeriote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Activated oxazaphosphorines are transported predominantly by erythrocytesM S Highley, D Schrijvers, A T Van Oosterom, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
European Journal of Cancer & Clinical Oncology|March 1, 1986
Two types of tumour sensitivity test compared for platinum derivativesL M van Putten, R J Middeldorp, M B Edelstein, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Cell kinetic factors, single drugs and combinationP Lelieveld, J H Mulder, M B Edelstein, et al.
European Journal of Cancer|May 1, 1978
Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapyJ H Mulder, M B Edelstein, P Lelieveld, et al.
Journal of Experimental Therapeutics & Oncology|November 1, 1996
Quantitative measurements of the efficacy of new anti-cancer agents on fresh human AML cells by using multivariate flow analysisA Nakeff, M A KuKuruga, J E Media, et al.
European Journal of Cancer & Clinical Oncology|July 1, 1983
Comparison between macroscopic and microscopic evaluation of tumour responsiveness using the subrenal capsule assayM B Edelstein, H H Fiebig, T Smink, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1984
Improvements and limitations of the subrenal capsule assay for determining tumour sensitivity to cytostatic drugsM B Edelstein, T Smink, D J Ruiter, et al.
Cancer Treatment Reports|January 1, 1983
Model studies in adjuvant chemotherapyJ H Mulder, J de Ruiter, M B Edelstein, et al.
Investigational New Drugs|January 1, 1990
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group studyM B Edelstein, J J Crowley, F A Valeriote, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 1998
Activated oxazaphosphorines are transported predominantly by erythrocytesM S Highley, D Schrijvers, A T Van Oosterom, et al.
Pageof 2